A 48-year-old man with a 15-year history of intravenous drug use presents with fatigue, jaundice, and right upper quadrant pain. He reports no previous hepatitis vaccination. Laboratory findings: HBsAg positive, Anti-HBc positive (total), Anti-HBc IgM negative, Anti-HBs negative, HBeAg positive, HBV DNA 2.5 × 10^6 IU/mL. Liver biopsy shows bridging fibrosis with portal-based inflammation and scattered acidophil bodies. Abdominal ultrasound reveals a nodular liver contour. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Chronic Hepatitis B with Advanced Fibrosis ### Serological Profile Analysis **Key Point:** The combination of HBsAg positivity, Anti-HBc total positivity, Anti-HBc IgM negativity, and high HBV DNA defines chronic hepatitis B with active viral replication. | Serological Marker | Result | Interpretation | |-------------------|--------|----------------| | HBsAg | Positive | Active HBV infection | | Anti-HBc (total) | Positive | Past or ongoing HBV exposure | | Anti-HBc IgM | Negative | NOT acute infection (rules out acute HAV/HBV) | | Anti-HBs | Negative | No protective immunity | | HBeAg | Positive | High viral replication | | HBV DNA | 2.5 × 10^6 IU/mL | Viremic (>10^5 = high replication) | **High-Yield:** Anti-HBc IgM is the hallmark of acute hepatitis B. Its absence here, combined with HBsAg positivity for >6 months (implied by 15-year IVDU history), confirms chronic infection. ### Histopathological Findings **Clinical Pearl:** Bridging fibrosis (METAVIR F3) with portal-based inflammation and acidophil bodies (apoptotic hepatocytes) indicates: - Active hepatic necroinflammation - Advanced fibrosis approaching cirrhosis - High risk of progression to decompensation **Mnemonic: ACID bodies** = Apoptotic Cells In Disease (marker of active hepatocyte injury in viral hepatitis) The nodular liver contour on ultrasound suggests cirrhotic remodeling, consistent with bridging fibrosis. ### Why This Is NOT Acute Hepatitis B **Warning:** Anti-HBc IgM negativity is the critical discriminator. Acute HBV would show: - Anti-HBc IgM **positive** - Often Anti-HBs **positive** (recovery phase) - Lower HBV DNA (typically <10^7 IU/mL but with acute inflammation) The 15-year IVDU history also makes acute infection implausible. ### Why This Is NOT Resolved Hepatitis B **Key Point:** Resolved HBV infection shows: - HBsAg **negative** - Anti-HBs **positive** (protective antibody) - Anti-HBc total **positive** (memory of exposure) This patient has HBsAg positive and Anti-HBs negative — active infection, not resolved. ### Why This Is NOT Carrier State **Clinical Pearl:** Inactive HBsAg carriers have: - HBsAg positive, but HBeAg **negative** - HBV DNA <10^3 IU/mL (or undetectable) - Minimal inflammation on biopsy - Normal ALT This patient has HBeAg positive, HBV DNA 2.5 × 10^6 IU/mL, and bridging fibrosis — all markers of **active replication** and **advanced disease**. ## Clinical Significance **High-Yield:** Chronic HBV with HBeAg positivity and HBV DNA >10^5 IU/mL is an indication for antiviral therapy (nucleos(t)ide analogues or interferon-alpha) to prevent progression to decompensated cirrhosis and hepatocellular carcinoma.